title: Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
authors.forename: E
authors.initials: E
authors.lastname: Ozyilkan
authors.forename: O
authors.initials: O
authors.lastname: Ozyilkan
authors.forename: D
authors.initials: D
authors.lastname: Firat
authors.forename: H
authors.initials: H
authors.lastname: Telatar
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D018281:Cholangiocarcinoma / Q000276:immunology*; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006512:Hepatitis B Core Antigens / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D003698:Hepatitis Delta Virus / Q000276:immunology; D006801:Humans; D007564:Japan; D008103:Liver Cirrhosis / Q000276:immunology; D008113:Liver Neoplasms / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000276:immunology; D014421:Turkey
chemical_list: D006508:Hepatitis Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens